In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, to explain how ...

This retrospective study evaluated the prognostic value of quantitative imaging features derived from fluorodeoxyglucose (FDG) PET in 195 patients with stage III non–small cell lung cancer (NSCLC) ...

In a direct comparison, FDG-PET proved superior to MRI with arterial spin labelling (ASL) for diagnosing and differentiating various forms of dementia; however, there remains a need for the latter ...

FDG PET imaging measures glucose uptake in the brain. It has long served as a proxy for neuronal health—but is it? In the October 13 Science Translational Medicine, researchers led by Christian Haass ...

Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2017 ...

Role of PET/CT in prognosticating post-transplant outcomes based on a new scoring system: Results of PIPET-M TRIAL. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...

Correctly distinguishing between related neurodegenerative diseases remains challenging for clinicians, because reliable markers do not yet exist for many disorders. In the July 22 Neurology, ...

Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...

Researchers from France have shown that hepatobiliary MR contrast agent uptake can predict survival in patients with resectable hepatocellular carcinoma (HCC) as well as 18 F-FDG PET/CT can. They ...

Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with eight or six cycles of eBEACOPP is very effective in patients with advanced-stage Hodgkin's lymphoma (HL), ...